|
Jul 2
|
Here’s Why NeoGenomics (NEO) Sold Off in Q1
|
|
Jul 1
|
NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
|
|
Jun 30
|
NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
|
|
May 28
|
NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
|
|
May 28
|
Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way
|
|
May 23
|
NeoGenomics introduces c-MET companion diagnostic for NSCLC
|
|
May 22
|
NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer
|
|
May 1
|
NeoGenomics price target lowered to $10 from $17 at Morgan Stanley
|
|
May 1
|
NeoGenomics Pays Off 1.25% Convertible Senior Notes
|
|
Apr 30
|
NeoGenomics Inc (NEO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Apr 29
|
Why NeoGenomics (NEO) Stock Is Nosediving
|
|
Apr 29
|
NeoGenomics (NEO) Reports Break-Even Earnings for Q1
|
|
Apr 29
|
NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform
|
|
Apr 29
|
NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops
|
|
Apr 29
|
NeoGenomics: Q1 Earnings Snapshot
|
|
Apr 29
|
NeoGenomics Reports First Quarter 2025 Results
|
|
Apr 28
|
NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For
|
|
Apr 23
|
Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 22
|
NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 22
|
NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting
|